Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Bocidelpar
Cat. No.:
0225LY-0857
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Bocidelpar is a modulator of the PPARδ receptor (EC50: 7.80 nM) that enhances the function and biogenesis of mitochondria in muscle cells affected by Duchenne Muscular Dystrophy.
Synonym:
2095128-20-2; ASP0367; MTB-1; ASP-0367; MA-0211; (3R)-3-methyl-6-[2-[[5-methyl-2-[4-(trifluoromethyl)phenyl]imidazol-1-yl]methyl]phenoxy]hexanoic acid; Hexanoic acid, 3-methyl-6-(2-((5-methyl-2-(4-(trifluoromethyl)phenyl)-1H-imidazol-1-yl)methyl)phenoxy)-, (3R)-; Hexanoic acid, 3-methyl-6-[2-[[5-methyl-2-[4-(trifluoromethyl)phenyl]-1H-imidazol-1-yl]methyl]phenoxy]-, (3R)-
CAS No.:
2095128-20-2
Compound CID:
126752383
Formula:
C25H27F3N2O3
Formula Weight:
460.49
Specification
Targets&IC50:
PPARδ: 7.80 nM(EC50)
Relative Density:
1.21 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Bocidelpar can be used in clinical pharmacology to examine the selective agonism of PPAR delta in metabolic disorders.
Library Information
Target:
PPAR
Receptor:
PPARδ
Pathways:
Metabolism; DNA damage/DNA repair
Plate Number:
AOCL-12
Plate Location:
a6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
50 mg/mL; 108.58 mM
